|
TRAMAL retard tablety 200 mg tbl plg 50x200 mg (blis.Al/PVC/PVDC)
200 mg
|
Tableta s predĺženým uvoľňovaním |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL retard tablety 200 mg tbl plg 50x200 mg (blis.PP/Al-biely)
200 mg
|
Tableta s predĺženým uvoľňovaním |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL retard tablety 200 mg tbl plg 50x200 mg (blis.PP/Al-priehľadný)
200 mg
|
Tableta s predĺženým uvoľňovaním |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL tvrdé kapsuly 50 mg cps dur 10x50 mg (blis.Al/PP)
50 mg
|
Tvrdá kapsula |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL tvrdé kapsuly 50 mg cps dur 10x50 mg (blis.Al/PVC/PVDC)
50 mg
|
Tvrdá kapsula |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL tvrdé kapsuly 50 mg cps dur 20x50 mg (blis.Al/PP)
50 mg
|
Tvrdá kapsula |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
TRAMAL tvrdé kapsuly 50 mg cps dur 20x50 mg (blis.Al/PVC/PVDC)
50 mg
|
Tvrdá kapsula |
N02AX02
|
STADA Arzneimittel AG |
—
|
|
Tramapran 37,5 mg/325 mg tbl 10x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramapran 37,5 mg/325 mg tbl 20x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramapran 37,5 mg/325 mg tbl 30x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramapran 37,5 mg/325 mg tbl 40x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramapran 37,5 mg/325 mg tbl 50x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramapran 37,5 mg/325 mg tbl 60x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al)
37.5 mg /325 mg
|
Tableta |
N02AJ13
|
Zentiva, k.s. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 10x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 20x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 30x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 40x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 50x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 60x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
Tramcet 37,5 mg/325 mg tablety tbl 90x37,5 mg/325 mg (blis.PVC/PVDC/Al)
37,5/325 mg v 1 tablete
|
Tableta |
N02AJ13
|
PharmaSwiss Česká republika s.r.o. |
—
|
|
TRANSTEC 35 µg/h emp tdm 10x20 mg (vre.papier/PET/PE/Al/surlyn)
35 µg/1 h
|
Transdermálna náplasť |
N02AE01
|
STADA Arzneimittel AG |
—
|
|
TRANSTEC 35 µg/h emp tdm 3x20 mg (vre.papier/PET/PE/Al/surlyn)
35 µg/1 h
|
Transdermálna náplasť |
N02AE01
|
STADA Arzneimittel AG |
—
|
|
TRANSTEC 35 µg/h emp tdm 5x20 mg (vre.papier/PET/PE/Al/surlyn)
35 µg/1 h
|
Transdermálna náplasť |
N02AE01
|
STADA Arzneimittel AG |
—
|
|
TRANSTEC 52,5 µg/h emp tdm 10x30 mg (vre.papier/PET/PE/Al/surlyn)
52,5 µg/1 h
|
Transdermálna náplasť |
N02AE01
|
STADA Arzneimittel AG |
—
|